Terms: = Uterine cancer AND MUC16, CA125, CA-125 AND Diagnosis
343 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in uterine Sarcoma.
Yang L; Cai Y; Wang Y; Huang Y; Zhang C; Ma H; Zhou JG
Technol Cancer Res Treat; 2024; 23():15330338241245924. PubMed ID: 38613349
[TBL] [Abstract] [Full Text] [Related]
3. Cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis.
Liu W; Ma J; Zhang J; Cao J; Hu X; Huang Y; Wang R; Wu J; Di W; Qian K; Yin X
EMBO Mol Med; 2024 Apr; 16(4):988-1003. PubMed ID: 38355748
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia.
Levin G; Matanes E; Brezinov Y; Ferenczy A; Pelmus M; Brodeur MN; Salvador S; Lau S; Gotlieb WH
Eur J Surg Oncol; 2024 Mar; 50(3):108006. PubMed ID: 38342041
[TBL] [Abstract] [Full Text] [Related]
6. Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
[TBL] [Abstract] [Full Text] [Related]
7. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
PeerJ; 2023; 11():e16424. PubMed ID: 38077439
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
9. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
Miller HA; Tran A; LyBarger KS; Frieboes HB
Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
[TBL] [Abstract] [Full Text] [Related]
10. uterine incarceration: a rare diagnosis in non-pregnant women.
Cruz LT; Reis-de-Carvalho C; Ribeirinho AL
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 38035678
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
12. Effects of coagulation function indicators and tumor markers on diagnosis and clinicopathological characteristics of endometrial cancer.
Li H; Liao H; Jing B; Wang Y
Int J Biol Markers; 2023 Dec; 38(3-4):214-222. PubMed ID: 37635376
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
Wu Q; Bai SN; Song LY; Wu WF; Han LN
Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
[TBL] [Abstract] [Full Text] [Related]
14. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
15. Fortuitously detected primary ovarian carcinoid tumor: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2023 Aug; 102(31):e34391. PubMed ID: 37543794
[TBL] [Abstract] [Full Text] [Related]
16. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
[TBL] [Abstract] [Full Text] [Related]
17. A Risk-scoring Model for Predicting Post-recurrence Survival in Patients With Endometrial Carcinoma.
Kolehmainen A; Pasanen A; Koivisto-Korander R; Bützow R; Loukovaara M
Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):472-477. PubMed ID: 37173220
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic Challenge: Distinguishing uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report.
Winarto H; Simatupang ONN; Calvin D; Siregar TP; Andrijono
J Radiol Case Rep; 2023 Apr; 17(4):1-12. PubMed ID: 37144233
[TBL] [Abstract] [Full Text] [Related]
19. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
20. Could uterine conservation be an option in presumed early-stage epithelial ovarian cancer?
Benoit L; Pajot C; Koual M; Nguyen-Xuan HT; Bentivegna E; Bats AS; Azaïs H
Arch Gynecol Obstet; 2023 Sep; 308(3):953-960. PubMed ID: 37031304
[TBL] [Abstract] [Full Text] [Related]
[Next]
